title: Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model.
abstract: Nasopharyngeal colonization is the first step in the interaction between Streptococcus pneumoniae (the pneumococcus) and its human host. Factors that contribute to clearance of colonization are likely to affect the spread of the pneumococcus and the rate of pneumococcal disease in the population. To identify host and bacterial factors contributing to this process, we examined the time course of colonization using genetically modified mice and pneumococci. Severe combined immunodeficient mice remained persistently colonized (>6 weeks). Major histocompatibility complex II-deficient mice, but not microMT mice, were unable to clear colonization and showed a diminished T helper 1 response. Thus, CD4+ T cells, rather than the generation of specific antibody, appear to be required for effective Th1-mediated clearance. In addition, the microbial pattern recognition receptor toll-like receptor 2 (TLR2), but not TLR4, was necessary for efficient clearance of colonization. In contrast, no role of complement component 3, inducible nitric oxide synthetase, interleukin 12 (IL-12), or IL-4 could be demonstrated. Expression of the pneumococcal toxin pneumolysin enhanced acute localized inflammatory responses and promoted clearance of colonization in a TLR4-independent manner. We conclude that both innate and CD4+ T-cell-mediated immunity and proinflammatory bacterial factors, rather than a humoral adaptive immune response, are important for clearance of S. pneumoniae from the murine nasopharynx.
authors.affiliation: University of Pennsylvania, 402A Johnson Pavilion, Philadelphia, PA 19104-6076, USA.
authors.forename: Annemarie M C
authors.initials: AM
authors.lastname: van Rossum
authors.forename: Elena S
authors.initials: ES
authors.lastname: Lysenko
authors.forename: Jeffrey N
authors.initials: JN
authors.lastname: Weiser
mesh_terms: D000818:Animals; D001426:Bacterial Proteins / Q000502:physiology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D003176:Complement C3 / Q000235:genetics / Q000502:physiology; D004195:Disease Models, Animal; D007113:Immunity, Innate / Q000276:immunology; D018664:Interleukin-12 / Q000235:genetics / Q000502:physiology; D015847:Interleukin-4 / Q000235:genetics / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D019001:Nitric Oxide Synthase / Q000235:genetics / Q000378:metabolism; D011008:Pneumococcal Infections / Q000276:immunology* / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000276:immunology*; D013301:Streptolysins / Q000502:physiology; D051195:Toll-Like Receptor 2 / Q000276:immunology
chemical_list: D001426:Bacterial Proteins; D003176:Complement C3; D013301:Streptolysins; D051195:Toll-Like Receptor 2; C032290:plY protein, Streptococcus pneumoniae; D018664:Interleukin-12; D015847:Interleukin-4; D019001:Nitric Oxide Synthase